ModelEdge
InMed Pharmaceuticals Inc.
INM
Filing type
8-K
Filing date
May 18, 2026
Updated
May 19, 2026 ยท 9:25 AM

Filing

8-KMaterial Contracts, Change in Company Ownership, Changes in Board, Management or Compensation, Reg. FD

Exhibits

EX-2.1AGREEMENT AND PLAN OF MERGER AND REORGANIZATION, DATED AS OF MAY 19, 2026, BY AND AMONG INMED PHARMACEUTICALS INC., INDIGO MERGER SUB CORP., INDIGO MERGER SUB II, LLC AND MENTARI THERAPEUTICS, INCEX-10.1FORM OF SHAREHOLDER SUPPORT AGREEMENTEX-10.2FORM OF STOCKHOLDER SUPPORT AGREEMENTEX-10.3FORM OF LOCK-UP AGREEMENTEX-10.4FORM OF CVR AGREEMENTEX-10.5FORM OF MENTARI SECURITIES PURCHASE AGREEMENTEX-99.1Material Contracts, Change in Company Ownership, Changes in Board, Management or Compensation, Reg. FDEX-99.2Material Contracts, Change in Company Ownership, Changes in Board, Management or Compensation, Reg. FDEX-99.3Material Contracts, Change in Company Ownership, Changes in Board, Management or Compensation, Reg. FDGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic